Bringing new drugs and therapeutics to market is an expensive and time-consuming process. With so many policies and procedures to track and maintain, many biopharmas use electronic quality management systems (or eQMS) to centrally manage and monitor compliance. When…
May is National Mystery Month, and although the holiday is technically a commemoration of mystery novels and authors, we thought it might be fun to celebrate in a different way –– by highlighting some of the weirdest, whackiest, and most…
Mental illnesses are some of the most common medical conditions, affecting more than 57 million Americans. To put those numbers into perspective, the U.S. Centers for Disease Control and Prevention (CDC) notes: 1 in 5 Americans will experience a…
Vendor oversight is an important element, and a regulatory requirement, of all clinical trials just as proper communication is essential to any healthy working relationship. Many sponsors outsource some or all of the clinical trial responsibilities to a CRO,…
Clinical trials are key to developing new drugs, medical devices, and therapies, but many never even make it off the ground. Consider the fact that 90% of new drug candidates fail and 80% of clinical trials are unable…
Bringing new drugs and compounds to market has always been expensive, but it’s become increasingly so over the last decade. Considering that up to 90% of drug candidates never make it to market, the biotech and pharma industries have…
Workforce turnover has always been a challenge for Clinical Research Organizations (CROs), but the problem has accelerated during the last decade. If you’ve ever taken an Uber, stayed at an AirBnB or hired a TaskRabbit, you are participating in…
This year has ushered in the third year of the COVID-19 pandemic. While the virus is something we’re all tired of hearing about, its lingering effects on drug research and development can’t be overstated. PPD, the clinical research branch…
More than 1,200 clinical trials featuring a decentralized or virtual component took place in 2022 –– a 28% increase from a year earlier. Though some trial sites are returning to in-person setups, a recent report from Clinical Trials Arena…
Workforce turnover has always been a challenge for Clinical Research Organizations (CROs), but the problem has accelerated during the last decade. A recent study, published by BDO, emphasizes this issue, noting that “turnover in CROs has hovered around 25%…
